Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Neuroscience

Volumn 32, Issue 1, 1989, Pages 213-226

  Mitchell, I J ^a   Clarke, C E ^a   Boyce, S ^a   Robertson, R G ^a   Peggs, D ^a   Sambrook, M A ^a   Crossman, A R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DEOXYGLUCOSE; RADIOISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; AUTORADIOGRAPHY; FEMALE; GLOBUS PALLIDUS; HISTOLOGY; MALE; MONKEY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; THALAMUS;

ANIMAL; AUTORADIOGRAPHY; BASAL GANGLIA; DEOXY SUGARS; DEOXYGLUCOSE; ENERGY METABOLISM; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MACACA FASCICULARIS; MALE; MPTP POISONING; PARKINSON DISEASE, SECONDARY; SUPPORT, NON-U.S. GOV'T;

EID: 0024397741     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(89)90120-6     Document Type: Article

References (49)

1. Subthalamotomy in treatment of Parkinsonian tremor
2. 14C]deoxyglucose labelling in optic tectum of the rattlesnake
3. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of MPTP
4. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of substantia nigra byN-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine
5. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine in the monkey and man
6. Interconnections and organization of pallidal and subthalamic nucleus neurons in the monkey
7. Connections of the subthalamic nucleus in the monkey
8. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders
9. A new experimental model of choreoathetosis in the primate
10. Regional brain uptake of 2-deoxyglucose inN-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey
11. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms
12. Basal ganglia mechanisms mediating experimental dyskinesia in the monkey
13. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex: the site of drug action and a hypothesis of the Neurol mechanisms of chorea
14. An autoradiographic study of the efferent connections of the globus pallidus inMacaco mulatto
15. Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study
16. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys
17. Origin and distribution of glutamate decar☐ylase in the nucleus subthalamicus of the cat
18. The basal ganglia and the locomotor regions
19. Alterations in neurotransmitter receptors and iron content in Parkinson's disease and Alzheimer's disease
20. Parkinsonism: onset, progression and mortality
21. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase
22. Projections of the globus pallidus and adjacent structures: an autoradiographic study in the monkey
23. Subthalamic neurons and their afferents to the globus pallidus and the substantia nigra in the rat: anatomical and electrophysiological study
24. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity
25. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism
26. Sites of the neurotoxic action of 1-methyl-4phenyl-l,2,3,6-tetrahydropyridine in the macaque monkey include the ventral temental area and the locus coeruleus
27. Common Neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography
28. 3H]2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus
29. Neural mechanisms mediating 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake
30. The role of the subthalamic nucleus in experimental chorea evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies
31. Surgical approach to tremor
32. Projections of the lentiform nucleus in the monkey
33. Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat
34. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems
35. MPTP-induced hemiparkinsonism in monkeys: effects ofl-DOPA on local cerebral glucose utilisation
36. 3H]muscimol binding in substantia nigra, entopedunclar nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography
37. The striatopallidal and striatomgral projections: two distinct fibre systems in primate
38. Striatal inhomogeneities and basal ganglia function
39. Changes in local cerebral glucose utilisation associated with Parkinson's syndrome induced by MPTP in the primate
40. Local cerebral metabolic effects ofl-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys
41. Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus
42. Pharmacological blockade of the globus pallidus-induced inhibitory response of subthalamic cells in the rat
43. New parallels between Parkinson's disease and MPTP-induced parkinsonism in the monkey
44. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat
45. Changes in the local cerebral metabolic rate for the MPTP primate model of Parkinson's disease
46. 14C ]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat
47. Pallidal and tegmental inhibition of oscillatory slow waves and unit activity in the subthalamic nucleus